Form 8-A12B THERMO FISHER SCIENTIFIC
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Thermo Fisher Scientific Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 04-2209186 | |
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
168 Third Avenue
Waltham, Massachusetts
|
02451 | |
| (Address of principal executive offices) | (Zip Code) |
Thermo Fisher Scientific (Finance I) B.V.
(Exact name of registrant as specified in its charter)
| The Netherlands | 98-1315372 | |
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
De Posthoornstraat 7
5048 AS Tilburg
The Netherlands
|
||
|
(Address of principal executive offices)
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
Title of each class
to be so registered
|
Name of each exchange on which
each class is to be registered
|
|
|
Floating Rate Senior Notes due 2027
|
New York Stock Exchange LLC
|
|
|
3.628% Senior Notes due 2035
|
New York Stock Exchange LLC
|
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the
following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the
following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement or Regulation A offering statement file number to which this form relates (if applicable): 333-285159
Securities to be registered pursuant to Section 12(g) of the Act: None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Thermo Fisher Scientific Inc. (“Thermo Fisher”) and Thermo Fisher Scientific (Finance I) B.V. (“Thermo Fisher International” and together with Thermo Fisher, the
“Registrants”) have filed with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”), a prospectus supplement, dated November 24, 2025 (the “Prospectus
Supplement”), and the accompanying prospectus, dated February 24, 2025 (the “Base Prospectus”). The Prospectus Supplement relates to the offering of €1,000,000,000 aggregate principal amount of Floating Rate Senior Notes due 2027 and
€1,100,000,000 aggregate principal amount of 3.628% Senior Notes due 2035 (collectively, the “Notes”) to be issued by Thermo Fisher International. The Notes will be fully and unconditionally guaranteed by Thermo Fisher.
|
Item 1.
|
Description of Registrant’s Securities to be Registered.
|
The descriptions under the heading “Description of the Notes” in the Prospectus Supplement and “Description of Thermo Fisher International Debt Securities” in the Base
Prospectus are incorporated by reference herein. Copies of such descriptions will be filed with The New York Stock Exchange.
|
Item 2.
|
Exhibits.
|
|
Exhibit No.
|
Description
|
|
Indenture, dated as of August 9, 2016, by and among Thermo Fisher International, as issuer, Thermo Fisher, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 of Thermo
Fisher’s Current Report on Form 8-K filed with the Commission on August 9, 2016).
|
|
|
Fifth Supplemental Indenture, dated as of December 1, 2025, among Thermo Fisher International, as issuer, Thermo Fisher, as guarantor, and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit
4.2 of Thermo Fisher’s Current Report on Form 8-K filed with the Commission on December 1, 2025).
|
|
|
Form of Floating Rate Senior Notes due 2027 (included in Exhibit 4.2).
|
|
|
Form of 3.628% Senior Notes due 2035 (included in Exhibit 4.2).
|
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934 the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned,
thereto duly authorized.
|
THERMO FISHER SCIENTIFIC INC.
|
||
|
Date: December 1, 2025
|
By:
|
/s/ Thomas B. Shropshire
|
|
Name: Thomas B. Shropshire
|
||
|
Title: Senior Vice President and General Counsel
|
||
| THERMO FISHER SCIENTIFIC (FINANCE I) B.V. | ||
|
Date: December 1, 2025
|
By:
|
/s/ Anthony H. Smith
|
|
Name: Anthony H. Smith
|
||
|
Title: Managing Director
|
||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thermo Fisher Scientific (TMO) PT Raised to $675 at Bernstein SocGen Group
- 4 Ways to Make Room for Better Living
- The Wendy's Company Confirms Receipt of Unsolicited Proposal from Trian Partners
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share